| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/18/2007 | WO2005116189A3 Compositions and use of inflammation-20 (inf-20) gene |
| 01/18/2007 | WO2005113017A3 Gfap-based gene therapy for treatment of retinal diseases |
| 01/18/2007 | WO2005056771A3 In vitro uptake of spam 1 (ph-20) by mammalian sperm |
| 01/18/2007 | WO2004087870A3 Neuronal cell lineages and methods of production thereof |
| 01/18/2007 | US20070016982 Transgenic plants with increased titerpene saponin levels |
| 01/18/2007 | US20070016981 Plant seed oil of a rapeseed plant having endogenous saturated fatty acids comprising from 22.9% to 26.3% stearate; compositions and methods of use of plant desaturase enzymes, especially Delta -9 desaturases, are provided; use in genetic engineering of plants |
| 01/18/2007 | US20070016980 viral replicase binds to the geminiviral origin of replication to stimulate replication of the targeting vector, whereby homologous recombination between target modifying polynucleotide and the target polynucleotide produces a modified target polynucleotide |
| 01/18/2007 | US20070016979 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/18/2007 | US20070016977 Gene resistant to aphis gossypii |
| 01/18/2007 | US20070016976 Plant genes involved in defense against pathogens |
| 01/18/2007 | US20070016975 Methods and compositions for reduced putrescine methyl transferase and reduced quinolate phosphoribosyl transferase in plants |
| 01/18/2007 | US20070016974 Nucleic acid molecules and other molecules associated with plants |
| 01/18/2007 | US20070016973 Selective plant growth using D-amino acids |
| 01/18/2007 | US20070016971 Constitutive promoter from the Taro bacilliform virus (TaBV) for expression of foreign or endogenous coding sequences in plants; transcript capable of modulating expression of a target gene; Alomae disease of taro (Colocasia esculenta), badnavirus |
| 01/18/2007 | US20070016970 Guinea pig-chymase |
| 01/18/2007 | US20070016968 Treatment of pain through expression of opioid receptors |
| 01/18/2007 | US20070016383 Method for the evolutionary design of biochemical reaction networks |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015737 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2007 | US20070015280 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery |
| 01/18/2007 | US20070015279 Methods of Selecting Pancreatic Endocrine Cells Using Protein Synthesis Inhibitors |
| 01/18/2007 | US20070015278 Methods of isolating differentiable cells from placental-associated tissue and uses thereof |
| 01/18/2007 | US20070015277 Substrate for cell transfer |
| 01/18/2007 | US20070015269 Crystals of DPP-IV |
| 01/18/2007 | US20070015262 Extracts from Ajuga reptans cell lines, their preparation and use |
| 01/18/2007 | US20070015259 Fusion partner for production of monoclonal rabbit antibodies |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015250 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/18/2007 | US20070015249 Chondroitin polymerase and DNA encoding the same |
| 01/18/2007 | US20070015247 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 01/18/2007 | US20070015239 Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 01/18/2007 | US20070015238 Production of pseudotyped recombinant AAV virions |
| 01/18/2007 | US20070015228 Using anti-idiotypic antibody to determine CD20 concentration of cell; screening for modulators for prevention and/or treatment of HIV infection and cancer |
| 01/18/2007 | US20070015225 Administering PC cell-derived growth factor (PCDGF); improves the efficiency of primary hematopoietic cell culture |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
| 01/18/2007 | US20070015211 Conformer-specific antibodies and method of use, thereof |
| 01/18/2007 | US20070015210 Embryoid Body - Based Screen |
| 01/18/2007 | US20070015207 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 01/18/2007 | US20070015202 Atlastin |
| 01/18/2007 | US20070015201 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 01/18/2007 | US20070015163 Novel full-length cDNA |
| 01/18/2007 | US20070015162 99 human secreted proteins |
| 01/18/2007 | US20070015144 Human cDNAs and proteins and uses thereof |
| 01/18/2007 | US20070015138 Methods for identifying agents and conditions that modulate neurogenesis |
| 01/18/2007 | US20070015136 Controlling dendritic cell maturation state in the lymphoid tissue equivalent of an artificial immune system |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014807 Multiplex vaccine |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014773 Compositions for regenerating defective or absent myocardium |
| 01/18/2007 | US20070014772 Engineered biografts for repair of damaged myocardium |
| 01/18/2007 | US20070014771 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/18/2007 | US20070014769 Adenovirus vectors comprising meganuclease-type endonucleases, and related systems |
| 01/18/2007 | US20070014759 Glycopegylated granulocyte colony stimulating factor |
| 01/18/2007 | US20070014724 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 01/18/2007 | CA2652767A1 Method for evaluating cell populations |
| 01/18/2007 | CA2652232A1 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| 01/18/2007 | CA2615208A1 Apparatus and methods for preparing tissue grafts |
| 01/18/2007 | CA2614361A1 Constitutive promoters from poplar and uses thereof |
| 01/18/2007 | CA2614191A1 Antisense antibacterial method and compound |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743936A1 Mesenchymal stem cell precursor |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743635A2 Gibberellins for the promotion of ulcer healing |
| 01/17/2007 | EP1743027A1 Mutant pneumolysin proteins |
| 01/17/2007 | EP1743025A2 Methods for production of regulatory t cells and uses thereof |
| 01/17/2007 | EP1743024A1 A new method of expanding cord blood cells |
| 01/17/2007 | EP1743023A1 Method of forming mesenchymal stem cells from embryonic stem cells |
| 01/17/2007 | EP1743022A2 Methods and compositions for hair growth |
| 01/17/2007 | EP1743021A1 Cell carrier and cell carrier containment devices containing regenerative cells |
| 01/17/2007 | EP1743020A1 Osteoclast culture vessels and methods of use |
| 01/17/2007 | EP1743012A2 Methods for generating neuronal cells from human embryonic stem cells and uses thereof |
| 01/17/2007 | EP1742658A2 Cellular permissivity factor for viruses, and uses thereof |
| 01/17/2007 | EP1742654A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 01/17/2007 | EP1742595A2 Cell permeable structural implant |
| 01/17/2007 | EP1490476A4 Endothelial cells derived from human embryonic stem cells |
| 01/17/2007 | EP1399480B1 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 01/17/2007 | EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation |
| 01/17/2007 | EP1326995B1 Method for synthesising peptides, peptide mimetics and proteins |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1259628B1 Methods for generating hypermutable yeast |
| 01/17/2007 | EP1228232B1 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP0920520B1 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it. |
| 01/17/2007 | CN1898561A Animal model for protease activity and liver damage |
| 01/17/2007 | CN1898383A Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 01/17/2007 | CN1898382A Method of selecting genomic DNA fragment |
| 01/17/2007 | CN1898380A Method for separating cell from mammal gland secretion |
| 01/17/2007 | CN1898379A Methods for producing cell lines stable in serum-free medium suspension culture |
| 01/17/2007 | CN1898378A Stem cell targeting using magnetic particles |
| 01/17/2007 | CN1898377A Human corneal endothelial cells and methods of obtaining and culturing cells for corneal cell transplantation |
| 01/17/2007 | CN1898375A Method and bioreactor for the cultivation and stimulation of three-dimensional vital and mechanically-resistant cell transplants |